ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,132Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 910

$528K Total Retail Price of All Prescriptions

Rank: 159 out of 910

372 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,556 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 381 357 1 1
AMLODIPINE BESYLATE 366 321 2 4
OMEPRAZOLE 365 301 3 5
DONEPEZIL HCL 335 334 4 32
METOPROLOL TARTRATE 309 277 5 7
FUROSEMIDE 309 267 5 9
TRAZODONE HCL 285 261 7 37
QUETIAPINE FUMARATE 232 200 8 70
SIMVASTATIN 209 192 9 3
LISINOPRIL 205 163 10 2
NAMENDA 204 204 11 57
POTASSIUM CHLORIDE 178 160 12 18
VENLAFAXINE HCL 174 152 13 192
SERTRALINE HCL 166 138 14 24
PREDNISONE 164 138 15 43
PAROXETINE HCL 159 135 16 50
DIVALPROEX SODIUM 132 130 17 73
ISOSORBIDE MONONITRATE ER 124 110 18 81
RISPERIDONE 117 114 19 67
GABAPENTIN 110 98 20 13
TAMSULOSIN HCL 107 100 21 29
CITALOPRAM HBR 103 90 22 19
METFORMIN HCL 103 103 22 6
PANTOPRAZOLE SODIUM 100 86 24 27
SEROQUEL 100 88 24 135
CARBIDOPA-LEVODOPA 97 89 26 91
WARFARIN SODIUM 94 77 27 11
DIGOXIN 92 69 28 64
CIPROFLOXACIN HCL 89 79 29 48
CLOPIDOGREL 87 73 30 35
ATORVASTATIN CALCIUM 85 80 31 14
MIRTAZAPINE 82 82 32 68
HYDROCODONE-ACETAMINOPHEN 79 72 S3 33 8
CEFDINIR 76 65 34 250
METOPROLOL SUCCINATE 74 59 35 21
METOCLOPRAMIDE HCL 73 59 36 149
HYDRALAZINE HCL 72 59 37 65
LEVETIRACETAM 71 44 38 98
CYMBALTA 66 55 39 58
ATENOLOL 59 51 40 10
HYDROCHLOROTHIAZIDE 58 49 41 12
AMIODARONE HCL 56 38 42 162
ALLOPURINOL 53 31 43 33
RANITIDINE HCL 53 21 43 28
NORTRIPTYLINE HCL 52 38 45 183
INSULIN SYRINGE 52 33 45 47
LACTULOSE 52 40 45 109
ZOLPIDEM TARTRATE 52 21 45 17
CARVEDILOL 51 45 49 36
VENLAFAXINE HCL ER 50 44 50 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.